Viewing StudyNCT00069030



Ignite Creation Date: 2024-05-05 @ 11:30 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00069030
Status: COMPLETED
Last Update Posted: 2021-10-14
First Post: 2003-09-12

Brief Title: Safety of and Immune Response to an HIV Vaccine VRC-HIVDNA009-00-VP Administered With Interleukin-2Immunoglobulin IL-2Ig DNA Adjuvant in Uninfected Adults
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
HIV Seronegativity View
HIV Preventive Vaccine View
AIDS Vaccines View
Vaccines DNA View
Dose-Response Relationship Immunologic View
Cytokines View
Plasmids View
Ig View
HIV-1 View
Adjuvants Immunologic View
Drug Administration Schedule View
Interleukin View
IL2 View
ILIg View